Becton, Dickinson and Company’s Barclays 27th Annual Global Healthcare Conference: Insights from Tom Polen and Chris DelOrefice
On March 11, 2025, Becton, Dickinson and Company (BDX) participated in the Barclays 27th Annual Global Healthcare Conference. The conference was held at the New York Marriott Marquis, and the BDX team, consisting of Tom Polen, Chairman, CEO, and President, and Chris DelOrefice, Executive Vice President and CFO, was in attendance. The call started abruptly with the following exchange:
“Everyone for joining us today. We are so pleased to have with us again this year the team from Becton, Dickinson, Tom Polen, Chairman, Chief Executive Officer and Chris DelOrefice, EVP and Chief Financial Officer.”
Company Overview
BDX is a leading medical technology company that produces, sells, and services a broad range of medical devices, laboratory equipment, and diagnostic products. The company operates in two segments: BD Medical and BD Diagnostics. BD Medical focuses on producing medical devices for injection, infusion, and surgery, while BD Diagnostics offers diagnostic systems and solutions for disease and infection detection.
Insights from the Conference
“I’m Tom Polen, Chairman, CEO, and President of Becton, Dickinson. We’re excited about the progress we’ve made in the last year. We’ve launched over 100 new products, expanded our presence in emerging markets, and continued to invest in R&D to drive innovation,” said Polen during the conference.
“Our BD Medical segment has seen strong growth, particularly in our infusion systems business. We’ve also made significant progress in our digital transformation, with the launch of our new digital health platform, BD Verity,” added DelOrefice.
Impact on Individuals
BDX’s innovations in medical devices and diagnostics can have a significant impact on individuals’ lives. For instance, its infusion systems can help manage chronic conditions such as diabetes and cancer more effectively. The digital health platform, BD Verity, can provide patients with real-time health data and insights, enabling them to make informed decisions about their health.
Impact on the World
BDX’s contributions to healthcare extend beyond individual lives. Its products and solutions can help improve healthcare delivery and outcomes on a global scale. For instance, its diagnostic products can aid in the early detection and diagnosis of diseases, reducing the burden on healthcare systems and improving patient outcomes. Its medical devices can help healthcare providers deliver care more efficiently and effectively, reducing costs and improving patient satisfaction.
Conclusion
BDX’s participation in the Barclays 27th Annual Global Healthcare Conference provided valuable insights into the company’s progress and future plans. With a focus on innovation, expansion, and digital transformation, BDX is well-positioned to continue making a positive impact on individuals’ lives and the healthcare industry as a whole.
- BDX is a leading medical technology company with a broad range of products and solutions.
- BDX’s infusion systems and digital health platform can help manage chronic conditions and provide real-time health data, respectively.
- BDX’s contributions to healthcare can improve healthcare delivery and outcomes on a global scale.
